candesant biomedical
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3145 Geary Blvd, San Francisco, Californ...Phone Number
(223) 667-9328Website
www.candesant.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About candesant biomedical
Founded in 2015 by proven innovators and entrepreneurs in the dermatology and aesthetic medicine industry, Candesant is a privately-held company dedicated to developing novel solutions for excessive sweating and hyperhidrosis. With Candesant's initial product, CDX-101, the company's goal is to provide a simple, elegant device that offers significant sweat reduction without the pain and tradeoffs of existing therapies.Explore more
candesant biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is candesant biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on candesant biomedical recently announced quarterly report
Click to see if candesant biomedical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
candesant biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if candesant biomedical is spiking on competitors!
Funding: Get notified immidiatlly once candesant biomedical has new funding data
Website visits: Recent activity has been detected on your website
Check if candesant biomedical has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at candesant biomedical
Product Launch: Get notified when candesant biomedical launches new products
Recommended Actions
Reach out to Masked Content who joined candesant biomedical as Masked Content
Find more new buyers
Compare Similar Companies to candesant biomedical
Compare insights from companies similar to candesant biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
candesant biomedical
<$5M
1-10
Private
$35M
2015
AT
Alexandra TudoranSenior Director, Consumer Marketing
Company Profile Activity
Activity Insights
candesant biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
candesant biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about candesant biomedical.
candesant biomedical financials insights
Gather financial insights about candesant biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series B
$35M
candesant biomedical Tech Stack
A closer look at the technologies used by candesant biomedical
See more technologies
candesant biomedical News & Media
Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™
NASHVILLE, Tenn., June 6, 2023 /PRNewswire/ -- Candesant Biomedical, Inc. ("Candesant"), a private medical device company focused on the development and commercialization of non-invasive treatments for hyperhidrosis or excessive sweating, today announced the closing of a Series B...Candesant Biomedical Receives FDA Clearance of Brella™¹, the First and Only 3-Minute SweatControl Patch™, to Significantly Reduce Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
New Non-Invasive Treatment Significantly Reduces Excessive Underarm Sweating and Significantly Improves Quality of Life – Including Reducing the Negative Impact of Excessive Sweating on Daily Activities – After a Single In-Office Treatment FDA Clearance Based on Data from Randomized,...Pivotal Clinical SAHARA Study Shows Candesant Biomedical's Investigational Sweat Control Patch Significantly Reduces Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)
SAHARA Meets Study Endpoints, Demonstrating Underarm Sweating Significantly Reduced Following Three-Minute In-Office Treatment NASHVILLE, Tenn., March 18, 2023 /PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development and...Candesant Biomedical Announces Late-Breaking Oral Presentation of Pivotal Clinical Trial Data for its Investigational Patch to Reduce Excessive Underarm Sweating (Primary Axillary Hyperhidrosis) at the American Academy of Dermatology 2023 Annual Meeting
NASHVILLE, Tenn., March 9, 2023 /PRNewswire/ -- Candesant Biomedical ("Candesant"), a private medical device company focused on the development of non-invasive treatments for hyperhidrosis or excessive sweating, today announced the acceptance of its pivotal SAHARA clinical trial data for...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding candesant biomedical
Sign Up For FreeTo access detailed company insights
Founded in 2015 by proven innovators and entrepreneurs in the dermatology and aesthetic medicine industry, Candesant is a privately-held company dedicated to developing novel solutions for excessive sweating and hyperhidrosis. With Candesant's initial product, CDX-101, the company's goal is to provide a simple, elegant device that offers significan... Read More
